One of medicine’s greatest challenges is the central nervous system (CNS). Cut skin heals. Broken bone mends. Nervous tissue, however, repairs itself very slowly or not at all. This is especially true in older patients. Moreover, diseases such as cancer of the brain are extremely difficult to treat because they are behind the blood-brain barrier. Most drugs can’t get past this extra layer of protection.

The best available therapies are incapable of effectively treating damage to the nervous system. Too often, trauma to the CNS causes permanent loss of function. Diseases of the nervous system are also particularly difficult to treat. One of these is ALS, or Lou Gehrig’s disease. ALS is a terminal progressive degeneration of central nervous system neurons. Typically, by the time of diagnosis, the disease is already advanced and patients have only years to live.

In the United States alone, there are 6,000–7,000 new diagnoses per year. The total U.S. population of ALS patients remains relatively stable, at only 30,000 or so ALS sufferers, however. This is because few ALS patients survive long beyond diagnosis. As the disease destroys the neurons of the central nervous system, muscle paralysis increases until the patient can no longer breathe or swallow. Asphyxiation results.

If nervous system tissue could be regrown, however, we could treat spinal cord injuries and neurological diseases like ALS. We could grow healthy neurons at damaged sites and restore function. All of this is becoming possible due to breakthroughs in the therapeutic use of stem cells.

But I’m excited to say that the ability to grow healthy nervous system tissue could become a reality thanks to a tiny company that I recommended to my Breakthrough Technology Alert readers last year…

Therefore, I’d like to introduce you to the leader in neurological stem cell therapeutics, still an early-stage company. If you invest in this company, not only will you be helping in developing breakthrough treatments for previously incurable CNS diseases and injuries, you will also be getting in “on the ground floor” and setting the stage to reap fantastic returns in the years ahead.

While I’d like to shout this company’s name from the rooftops, it wouldn’t be fair to my premium readers, who’ve paid for the privilege of my research. That said, I want to make sure that Sleuth readers get the opportunity to take advantage of the enormous gain potential this stock has to offer, so I’d like to invite you to join the ranks of my Breakthrough Technology Alert risk free…

All you have to do is click here to learn more…

For Transformational Profits,
Patrick Cox
Penny Sleuth

July 8, 2010

Patrick Cox

Patrick Cox has lived deep inside the world of transformative technologies for over 25 years. In the 1980s, he worked in computer software development and manufacturing. By the mid-1990s, he worked as a consultant for Netscape — the company that handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured Patrick's research numerous times. He's also appeared on Crossfire and Nightline. Patrick has been quoted by The Wall Street Journal and Reason magazine. His expertise brought him to Agora Financial, where he now heads Breakthrough Technology Alert, the only place you'll find the truly transformational technologies that offer exponential gains.

View articles by Patrick Cox